Skip to main content
Erschienen in: International Orthopaedics 11/2012

01.11.2012 | Original Paper

Cysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model

verfasst von: Soenke Percy Frey, Stefanie Doht, Lars Eden, Stefan Dannigkeit, Norbert Schuetze, Rainer H. Meffert, Hendrik Jansen

Erschienen in: International Orthopaedics | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Open fractures with severe soft-tissue trauma are predisposed to poor bone healing. The vital coupling between osteo- and angiogenesis is disturbed. Cysteine-rich protein 61 (CYR61) is an angiogenic inducer promoting vascularisation. However, little is known about the effect of CYR61 on the callus regenerate after acute musculoskeletal trauma. Therefore, our aim was to determine whether local administration of CYR61: (1) has an influence on callus formation and remodelling, (2) increases bone volume and (3) partially restores callus stability.

Methods

A musculoskeletal trauma was created in 20 rabbits. To simulate fracture-site debridement, the limb was shortened. In the test group, a CYR61-coated collagen matrix was locally applied around the osteotomy. After ten days, gradual distraction was commenced (0.5 mm/12 h) to restore the original length. New bone formation was evaluated histomorphometrically, radiographically and biomechanically.

Results

Osseus consolidation occured in all animals. Average maximum callus diameter was higher in the test group [1.39 mm; standard deviation (SD) = 0.078 vs 1.26 mm (SD = 0.14); p = 0.096]. In addition, bone volume was higher (p = 0.11) in the test group, with a mean value of 49.73 % (SD = 13.68) compared with 37.6 % (SD = 5.91). Torsional strength was significantly higher (p = 0.005) in the test group [105.43 % (SD = 31.68 %) vs. 52.57 % (SD = 24.39)]. Instead, stiffness of the newly reconstructed callus decreased (64.21 % (SD = 11.52) vs. 71.30 % (SD = 32.25) (p = 0.81)).

Conclusions

CYR61 positively influences callus regenerate after acute trauma, not only histologically and radiographically but also biomechanically, most probably by a CYR61-associated pathway.
Literatur
1.
Zurück zum Zitat Meffert RH, Tis JE, Inoue N, McCarthy EF, Brug E, Chao EY (2000) Primary resective shortening followed by distraction osteogenesis for limb reconstruction: a comparison with simple lengthening. J Orthop Res 18(4):629–636. doi:10.1002/jor.1100180416 PubMedCrossRef Meffert RH, Tis JE, Inoue N, McCarthy EF, Brug E, Chao EY (2000) Primary resective shortening followed by distraction osteogenesis for limb reconstruction: a comparison with simple lengthening. J Orthop Res 18(4):629–636. doi:10.​1002/​jor.​1100180416 PubMedCrossRef
2.
Zurück zum Zitat Mollenhoff G, Josten C, Muhr G (1997) Callotaxis--osteogenesis by stretching--a conservative possibility for restoring leg length after post-traumatic primary tibial shortening? Zentralbl Chir 122(11):970–973PubMed Mollenhoff G, Josten C, Muhr G (1997) Callotaxis--osteogenesis by stretching--a conservative possibility for restoring leg length after post-traumatic primary tibial shortening? Zentralbl Chir 122(11):970–973PubMed
3.
Zurück zum Zitat Betz AM, Hierner R, Baumgart R, Stock W, Sebisch E, Kettler M, Schweiberer L (1998) Primary shortening–secondary lengthening. A new treatment concept for reconstruction of extensive soft tissue and bone injuries after 3rd degree open fracture and amputation of the lower leg. Handchir Mikrochir Plast Chir 30(1):30–39PubMed Betz AM, Hierner R, Baumgart R, Stock W, Sebisch E, Kettler M, Schweiberer L (1998) Primary shortening–secondary lengthening. A new treatment concept for reconstruction of extensive soft tissue and bone injuries after 3rd degree open fracture and amputation of the lower leg. Handchir Mikrochir Plast Chir 30(1):30–39PubMed
5.
Zurück zum Zitat Ivkovic A, Marijanovic I, Hudetz D, Porter RM, Pecina M, Evans CH (2011) Regenerative medicine and tissue engineering in orthopaedic surgery. Front Biosci (Elite Ed) 3:923–944 Ivkovic A, Marijanovic I, Hudetz D, Porter RM, Pecina M, Evans CH (2011) Regenerative medicine and tissue engineering in orthopaedic surgery. Front Biosci (Elite Ed) 3:923–944
6.
Zurück zum Zitat Schmid J, Wallkamm B, Hammerle CH, Gogolewski S, Lang NP (1997) The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 8(3):244–248PubMedCrossRef Schmid J, Wallkamm B, Hammerle CH, Gogolewski S, Lang NP (1997) The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 8(3):244–248PubMedCrossRef
8.
Zurück zum Zitat Groothuis A, Duda GN, Wilson CJ, Thompson MS, Hunter MR, Simon P, Bail HJ, van Scherpenzeel KM, Kasper G (2010) Mechanical stimulation of the pro-angiogenic capacity of human fracture haematoma: involvement of VEGF mechano-regulation. Bone 47(2):438–444. doi:10.1016/j.bone.2010.05.026 PubMedCrossRef Groothuis A, Duda GN, Wilson CJ, Thompson MS, Hunter MR, Simon P, Bail HJ, van Scherpenzeel KM, Kasper G (2010) Mechanical stimulation of the pro-angiogenic capacity of human fracture haematoma: involvement of VEGF mechano-regulation. Bone 47(2):438–444. doi:10.​1016/​j.​bone.​2010.​05.​026 PubMedCrossRef
10.
Zurück zum Zitat Lienau J, Schell H, Epari DR, Schutze N, Jakob F, Duda GN, Bail HJ (2006) CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability. J Orthop Res 24(2):254–262. doi:10.1002/jor.20035 PubMedCrossRef Lienau J, Schell H, Epari DR, Schutze N, Jakob F, Duda GN, Bail HJ (2006) CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability. J Orthop Res 24(2):254–262. doi:10.​1002/​jor.​20035 PubMedCrossRef
11.
Zurück zum Zitat Kireeva ML, Mo FE, Yang GP, Lau LF (1996) Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 16(4):1326–1334PubMed Kireeva ML, Mo FE, Yang GP, Lau LF (1996) Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 16(4):1326–1334PubMed
13.
15.
Zurück zum Zitat Babic AM, Kireeva ML, Kolesnikova TV, Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95(11):6355–6360PubMedCrossRef Babic AM, Kireeva ML, Kolesnikova TV, Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95(11):6355–6360PubMedCrossRef
16.
Zurück zum Zitat Ohashi S, Ohnishi I, Kageyama T, Fukuda S, Tsuchiya A, Imai K, Matsuyama J, Nakamura K (2005) Effect of vascularity on canine distracted tibial callus consolidation. Clin Orthop Relat Res 438:253–259PubMedCrossRef Ohashi S, Ohnishi I, Kageyama T, Fukuda S, Tsuchiya A, Imai K, Matsuyama J, Nakamura K (2005) Effect of vascularity on canine distracted tibial callus consolidation. Clin Orthop Relat Res 438:253–259PubMedCrossRef
17.
Zurück zum Zitat Grote K, Salguero G, Ballmaier M, Dangers M, Drexler H, Schieffer B (2007) The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood 110(3):877–885. doi:10.1182/blood-2006-07-036202 PubMedCrossRef Grote K, Salguero G, Ballmaier M, Dangers M, Drexler H, Schieffer B (2007) The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration. Blood 110(3):877–885. doi:10.​1182/​blood-2006-07-036202 PubMedCrossRef
18.
Zurück zum Zitat Leu SJ, Lam SC, Lau LF (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 277(48):46248–46255. doi:10.1074/jbc.M209288200 PubMedCrossRef Leu SJ, Lam SC, Lau LF (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 277(48):46248–46255. doi:10.​1074/​jbc.​M209288200 PubMedCrossRef
19.
Zurück zum Zitat Chen N, Leu SJ, Todorovic V, Lam SC, Lau LF (2004) Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 279(42):44166–44176. doi:10.1074/jbc.M406813200 PubMedCrossRef Chen N, Leu SJ, Todorovic V, Lam SC, Lau LF (2004) Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 279(42):44166–44176. doi:10.​1074/​jbc.​M406813200 PubMedCrossRef
20.
21.
Zurück zum Zitat Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130(12):2779–2791PubMedCrossRef Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130(12):2779–2791PubMedCrossRef
22.
Zurück zum Zitat Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277(39):36288–36295. doi:10.1074/jbc.M201674200 PubMedCrossRef Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277(39):36288–36295. doi:10.​1074/​jbc.​M201674200 PubMedCrossRef
23.
Zurück zum Zitat Dean RA, Butler GS, Hamma-Kourbali Y, Delbe J, Brigstock DR, Courty J, Overall CM (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 27(24):8454–8465. doi:10.1128/MCB.00821-07 PubMedCrossRef Dean RA, Butler GS, Hamma-Kourbali Y, Delbe J, Brigstock DR, Courty J, Overall CM (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 27(24):8454–8465. doi:10.​1128/​MCB.​00821-07 PubMedCrossRef
24.
Zurück zum Zitat Mori S, Akagi M, Kikuyama A, Yasuda Y, Hamanishi C (2006) Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system. J Orthop Res 24(4):653–663. doi:10.1002/jor.20076 PubMedCrossRef Mori S, Akagi M, Kikuyama A, Yasuda Y, Hamanishi C (2006) Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system. J Orthop Res 24(4):653–663. doi:10.​1002/​jor.​20076 PubMedCrossRef
25.
Zurück zum Zitat Wolf N, Yang W, Dunk CE, Gashaw I, Lye SJ, Ring T, Schmidt M, Winterhager E, Gellhaus A (2010) Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1{alpha} and transforming-growth factor-{beta}3 in the human trophoblast. Endocrinology 151(6):2835–2845. doi:10.1210/en.2009-1195 PubMedCrossRef Wolf N, Yang W, Dunk CE, Gashaw I, Lye SJ, Ring T, Schmidt M, Winterhager E, Gellhaus A (2010) Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1{alpha} and transforming-growth factor-{beta}3 in the human trophoblast. Endocrinology 151(6):2835–2845. doi:10.​1210/​en.​2009-1195 PubMedCrossRef
26.
Zurück zum Zitat Athanasopoulos AN, Schneider D, Keiper T, Alt V, Pendurthi UR, Liegibel UM, Sommer U, Nawroth PP, Kasperk C, Chavakis T (2007) Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem 282(37):26746–26753. doi:10.1074/jbc.M705200200 PubMedCrossRef Athanasopoulos AN, Schneider D, Keiper T, Alt V, Pendurthi UR, Liegibel UM, Sommer U, Nawroth PP, Kasperk C, Chavakis T (2007) Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem 282(37):26746–26753. doi:10.​1074/​jbc.​M705200200 PubMedCrossRef
28.
Zurück zum Zitat Crockett JC, Schutze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ (2007) The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Endocrinology 148(12):5761–5768. doi:10.1210/en.2007-0473 PubMedCrossRef Crockett JC, Schutze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ (2007) The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Endocrinology 148(12):5761–5768. doi:10.​1210/​en.​2007-0473 PubMedCrossRef
29.
Zurück zum Zitat Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2010) Strontium ranelate enhances callus strength more than PTH 1–34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 86(1):82–89. doi:10.1007/s00223-009-9317-8 PubMedCrossRef Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2010) Strontium ranelate enhances callus strength more than PTH 1–34 in an osteoporotic rat model of fracture healing. Calcif Tissue Int 86(1):82–89. doi:10.​1007/​s00223-009-9317-8 PubMedCrossRef
30.
Zurück zum Zitat Claes L, Blakytny R, Gockelmann M, Schoen M, Ignatius A, Willie B (2009) Early dynamization by reduced fixation stiffness does not improve fracture healing in a rat femoral osteotomy model. J Orthop Res 27(1):22–27. doi:10.1002/jor.20712 PubMedCrossRef Claes L, Blakytny R, Gockelmann M, Schoen M, Ignatius A, Willie B (2009) Early dynamization by reduced fixation stiffness does not improve fracture healing in a rat femoral osteotomy model. J Orthop Res 27(1):22–27. doi:10.​1002/​jor.​20712 PubMedCrossRef
31.
Zurück zum Zitat Histing T, Marciniak K, Scheuer C, Garcia P, Holstein JH, Klein M, Matthys R, Pohlemann T, Menger MD (2011) Sildenafil accelerates fracture healing in mice. J Orthop Res 29(6):867–873. doi:10.1002/jor.21324 PubMedCrossRef Histing T, Marciniak K, Scheuer C, Garcia P, Holstein JH, Klein M, Matthys R, Pohlemann T, Menger MD (2011) Sildenafil accelerates fracture healing in mice. J Orthop Res 29(6):867–873. doi:10.​1002/​jor.​21324 PubMedCrossRef
Metadaten
Titel
Cysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model
verfasst von
Soenke Percy Frey
Stefanie Doht
Lars Eden
Stefan Dannigkeit
Norbert Schuetze
Rainer H. Meffert
Hendrik Jansen
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
International Orthopaedics / Ausgabe 11/2012
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-012-1659-6

Weitere Artikel der Ausgabe 11/2012

International Orthopaedics 11/2012 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.